The research has been published in Cancer Letters. Yes, it is PEER-REVIEWED. • www.sciencedirect.com/science/arti...

In a new study led by Johns Hopkins Medicine, the drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast cancer bone metastasis). RK-33 was previously shown to help treat other types of cancer and viral illnesses.